Frequency and Mutation Patterns of Resistance in Patients with Chronic Hepatitis B Infection Treated with Nucleos(t)ide Analogs in Add-On and Switch Strategies


Creative Commons License

SAYAN M. , AKHAN S. , Senturk O.

HEPATITIS MONTHLY, cilt.11, ss.835-842, 2011 (SCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 11 Konu: 10
  • Basım Tarihi: 2011
  • Doi Numarası: 10.5812/kowsar.1735143x.775
  • Dergi Adı: HEPATITIS MONTHLY
  • Sayfa Sayıları: ss.835-842

Özet

Background: Treatment for chronic hepatitis B (CHB) has improved over the last 10 years mainly due to the development of effective oral antiviral agents [nucleoside/nucleotide analogs (NUCs)].